AI dietary support for recovery after rectal cancer surgery
This trial tests an artificial intelligence-based dietary care system to help patients manage their nutrition during recovery from rectal cancer surgery. It aims to improve dietary habits and overall recovery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You must be able to communicate in Mandarin or Taiwanese and have clear consciousness.
- You must have a confirmed diagnosis of rectal adenocarcinoma (a type of rectal cancer).
- You must be scheduled for or have had radical rectal resection (surgery to remove the rectum) or such surgery combined with temporary stoma closure.
- You must not have other intestinal disorders like other tumors, bloating, obstruction, ulcerative colitis, or irritable bowel syndrome.
- You must have internet access and be able to use a smartphone.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether an AI-assisted app can help hospitalized patients prepare better for a colonoscopy. It may make the bowel-cleansing process easier and more effective.
This trial uses artificial intelligence to help doctors check how well you recover after a gastrointestinal (GI) endoscopy with sedation. It aims to make recovery assessments more accurate and could lead to better care during your procedure.
This study uses artificial intelligence and a smartphone app to help monitor your recovery after lung cancer surgery. The goal is to track your symptoms and provide personalized guidance to support your healing and overall well-being.
This trial tests an AI-assisted program that helps manage cancer care, especially for patients who also have other health conditions. If you join, the program may help coordinate your treatment and monitor your health, possibly leading to better outcomes.
This trial tests an AI-based platform to help plan the best surgery for people with colon or rectal cancer. It aims to improve decision-making by both doctors and patients.
This trial tests a machine-learning (AI) system that may help guide surgeons during robotic rectal cancer operations. It’s meant to support safer, more accurate surgery while comparing outcomes to standard surgical guidance.
Hear when a new AI Care Device trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.